Agenda Tennessee Community-Engagement Research Alliance Against - - PowerPoint PPT Presentation

agenda
SMART_READER_LITE
LIVE PREVIEW

Agenda Tennessee Community-Engagement Research Alliance Against - - PowerPoint PPT Presentation

Tennessee Health Disparities Task Force Agenda Tennessee Community-Engagement Research Alliance Against COVID-19 ( TN CEAL) Member Comments/Announcements Office of Health Disparities Elimination October 22, 2020


slide-1
SLIDE 1

Tennessee Health Disparities Task Force

Agenda

Tennessee Community-Engagement Research Alliance Against COVID-19 ( TN CEAL) Member Comments/Announcements

Office of Health Disparities Elimination October 22, 2020

https://www.tn.gov/health/health-program-areas/dmhde/covid-19-health-disparity-task-force.html

slide-2
SLIDE 2

Subhead here

  • Body copy here

Tennessee Community-Engaged Alliance against COVID 19 (TN CEAL)

Paul D. Juarez, PhD, Professor

  • Dept. Family & Community Medicine

October 22, 2020

slide-3
SLIDE 3

Community Engaged Alliance Against COVID-19

TN Statewide CEAL

  • Paul D. Juarez, PhD, Principal Investigator
  • Neely Williams, EdD, Director, Community Engagement

West Tennessee CEAL RRC

  • Altha Stewart, MD, West TN Regional CEAL co-PI
  • Jim Bailey, MD, West TN Regional CEAL co-PI
  • Cherokee Health Systems

Central Tennessee CEAL RRC

  • Stephania Miller Hughes, PhD, Central TN Regional CEAL co-PI
  • Consuelo Williams, MD, Central TN Regional CEAL co-PI
  • Matthew Walker Comprehensive Health Center

East TN CEAL RRC

  • Parinda Khatry, PhD, Cherokee Health Systems, East TN

Regional CEAL co-PI

  • Abigail Mann, MD, ETSU, East TN Regional CEAL co-PI
  • Cherokee Health Systems
slide-4
SLIDE 4

Program Objectives

Objective 1: to conduct urgent community- engaged research and outreach focused on:

  • COVID-19 awareness and education
  • the widespread misinformation about

COVID-19 and promote an evidence- based response to the disease Objective 2: to promote and facilitate inclusion

  • f diverse racial and ethnic populations

disproportionately affected by the pandemic in COVID-19 vaccine trials

slide-5
SLIDE 5

Research Project

Hypothesis: Vulnerable populations that receive COVID-19 health education plus assistance in addressing social inequities will experience better outcomes than those who receive health education only Social Inequities:

  • Food
  • Personal protective equipment (PPE)
  • Technology/internet
  • Health/mental health care
  • Income/Social supports
slide-6
SLIDE 6

Outcomes

  • COVID-19 knowledge, awareness and

adaptation of preventive measures

  • COVID-19 testing
  • Vaccine readiness
  • Vaccine uptake
  • Participation in COVID-19 vaccine trials
slide-7
SLIDE 7

Community-based Participatory Research

Research Design

  • Pre-post survey measures
  • Recruitment: referrals from CHCs and community

partners

  • Target vulnerable populations
  • Recruitment will begin in January 2021

Procedures

  • Community Participation
  • Development/approval of surveys
  • Development of procedures
  • Identification of vulnerable populations
  • Recruitment and referral
  • Dissemination of information
slide-8
SLIDE 8

Recruitment for COVID-19 Vaccine Trials

Barriers

  • Misinformation
  • History of mistrust
  • Lack of Knowledge and Awareness
  • Anti-vax beliefs
  • Political dynamics

Overall strategy

  • Embed in a broader COVID-19 campaign
  • Health promotion
  • Clinical care
  • Testing
  • Social inequities
slide-9
SLIDE 9

COVID-19 Vaccine & Vaccine Trials

Develop tailored messages:

  • Racial/ethnic differences
  • Culture/lived experiences
  • Linguistic
  • Literacy
  • Community

Identify/engage trusted persons from target community

slide-10
SLIDE 10

COVID-19 Vaccine Trials

There are 50 COVID-19 vaccine trials at different phases Stage III Trials: Nashville

  • Moderna (mRNA-1273) VUMC-
  • Novavax—(NVX-CoV2373) Meharry

(expected to start in November;

  • Sinofax (CoronaVac) Meharry will start in

Dec/Jan

  • AstraZeneca (AZD1222) Clinical Research

Associates /Metro Public Health Dept.

slide-11
SLIDE 11

Other Phase 3 COVID-19 Vaccine Trials

  • Pfizer/BioNTech (BNT162)
  • Janssen (Ad26.COV2.S)
  • Eli Lilly (Blaze-2)
  • Regeneron (Gilead)
  • Johnson & Johnson (JNJ-7846735)
  • CanSino Biologics (Ad5-nCoV)
slide-12
SLIDE 12

Open Invitation to Join with us

TN CEAL Program invites the TDH/OMH/

Health Disparities Task Force and members to:

  • Participate in statewide research project to

increase COVID-19 awareness & safety

  • Assist with the tailoring of COVID-19

messaging to different populations

  • Participate in bi-weekly regional CEAL RRC

meetings

  • Participate in bi-weekly, statewide research

meetings

  • Participate in monthly statewide TN CEAL

meeting

slide-13
SLIDE 13

TN CEAL Program

Paul D. Juarez, PhD, Principal Investigator Department of Family & Community Med Meharry Medical College pjuarez@mmc.edu Thank you

slide-14
SLIDE 14

Member Comments (5 min.) Q & A

slide-15
SLIDE 15

Upcoming COVID-19 Testing Events

Saturday, October 24, 2020, 9:00am-12:00pm

  • Grundy County
  • Grundy County High School, 24970 TN-108, Coalmont, TN 37313
  • Fentress County
  • Fentress County Senior Citizens Center, 308 South Main St.,

Jamestown, TN 38556

  • Dyer County
  • Dyersburg High School, 125 US-51 Bypass, Dyersburg, TN 38024

Saturday, October 24, 2020, 10:00am-1:00pm

  • Hardeman County
  • Jones Chapel Missionary Baptist Church, 3190 Hwy 18 S, Grand

Junction, TN 38039

slide-16
SLIDE 16

Questions??

Please contact Monique Anthony at 629-215-0642

  • r

Minority.Health@tn.gov